A novel ETV6-PDGFRB fusion transcript missed by standard screening in a patient with an imatinib responsive chronic myeloproliferative disease

Leukemia. 2007 Aug;21(8):1839-41. doi: 10.1038/sj.leu.2404728. Epub 2007 May 17.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amino Acid Sequence
  • Antineoplastic Agents / therapeutic use*
  • Base Sequence
  • Benzamides
  • Chronic Disease
  • Genetic Testing
  • Humans
  • Imatinib Mesylate
  • Male
  • Molecular Sequence Data
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / drug therapy*
  • Myeloproliferative Disorders / genetics
  • Oncogene Proteins, Fusion / genetics*
  • Piperazines / therapeutic use*
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • ETV6-PDGFRB fusion protein, human
  • Oncogene Proteins, Fusion
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases